BofA analyst Adam Ron downgraded Oscar Health (OSCR) to Underperform from Neutral with a price target of $13.50, down from $21.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter